CLX
The Clorox Company NYSE$87.11
Mkt Cap $10.8B
52w Low $93.39
-13.1% of range
52w High $141.50
50d MA $109.16
200d MA $113.54
P/E (TTM)
13.3x
EV/EBITDA
12.5x
P/B
22.3x
Debt/Equity
9.0x
ROE
-619.2%
P/FCF
19.5x
RSI (14)
—
ATR (14)
—
Beta
0.65
50d MA
$109.16
200d MA
$113.54
Avg Volume
2.7M
About
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; prof…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 1.55 | 1.64 | +5.8% | 96.44 | -5.7% | -9.7% | — | — | — | — | — | — |
| Feb 3, 2026 | AMC | 1.43 | 1.39 | -2.8% | 114.98 | -1.0% | +2.4% | +2.3% | +3.8% | +4.0% | +5.6% | -1.1% | — |
| Nov 3, 2025 | AMC | 0.82 | 0.85 | +3.9% | 109.14 | +2.2% | +1.2% | -0.2% | -2.6% | -1.6% | -4.1% | -3.6% | — |
| Jul 31, 2025 | AMC | 2.20 | 2.87 | +30.5% | 125.56 | +1.4% | -2.0% | -1.1% | -0.2% | -0.0% | +0.4% | -4.4% | — |
| May 5, 2025 | AMC | 1.55 | 1.45 | -6.5% | 138.39 | -3.2% | -2.4% | -1.4% | -0.4% | -2.6% | -0.2% | -6.3% | — |
| Feb 3, 2025 | AMC | 1.39 | 1.55 | +11.5% | 159.78 | -3.6% | -7.2% | -8.7% | -7.6% | -7.1% | -7.9% | -6.3% | — |
| Oct 30, 2024 | AMC | 1.41 | 1.86 | +31.9% | 156.51 | +3.4% | +1.3% | +4.2% | +3.8% | +3.8% | +4.0% | +6.8% | — |
| Aug 1, 2024 | AMC | 1.56 | 1.82 | +16.7% | 134.14 | +5.9% | +7.4% | +6.4% | +6.8% | +7.2% | +7.6% | +20.1% | — |
| Apr 30, 2024 | AMC | 1.36 | 1.71 | +25.7% | 147.87 | -5.4% | -5.6% | -5.5% | -6.5% | -5.8% | -4.5% | -12.7% | — |
| Feb 1, 2024 | AMC | 1.08 | 2.16 | +100.0% | 148.04 | +7.1% | +5.6% | +4.3% | +4.5% | +5.1% | +4.2% | +2.0% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Evercore ISI | Maintains | Underperform → Underperform | — | $96.44 | $90.99 | -5.7% | -9.7% | — | — | — | — |
| May 1 | Citigroup | Maintains | Neutral → Neutral | — | $96.44 | $90.99 | -5.7% | -9.7% | — | — | — | — |
| May 1 | JP Morgan | Maintains | Underweight → Underweight | — | $96.44 | $90.99 | -5.7% | -9.7% | — | — | — | — |
| May 1 | UBS | Maintains | Neutral → Neutral | — | $96.44 | $90.99 | -5.7% | -9.7% | — | — | — | — |
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $96.44 | $90.99 | -5.7% | -9.7% | — | — | — | — |
| Apr 23 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $96.85 | $97.44 | +0.6% | +0.8% | +1.9% | -0.2% | -0.3% | -2.1% |
| Apr 21 | Jefferies | Maintains | Buy → Buy | — | $102.17 | $102.31 | +0.1% | -2.5% | -5.2% | -4.4% | -3.4% | -5.4% |
| Apr 17 | JP Morgan | Downgrade | Neutral → Underweight | — | $102.38 | $102.40 | +0.0% | +2.1% | -0.2% | -2.7% | -5.4% | -4.6% |
| Apr 15 | Citigroup | Maintains | Neutral → Neutral | — | $104.44 | $104.32 | -0.1% | -1.5% | -2.0% | +0.1% | -2.2% | -4.6% |
| Apr 15 | Barclays | Maintains | Underweight → Underweight | — | $104.44 | $104.32 | -0.1% | -1.5% | -2.0% | +0.1% | -2.2% | -4.6% |
Recent Filings
8-K · 7.01
! Medium
The Clorox Company -- 8-K 7.01: Regulation FD Disclosure
Apr 30
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Clorox's acquisition of GOJO expands its product portfolio across disinfection and hygiene categories, potentially boosting revenue growth and margin synergies while strengthening competitive positioning against larger rivals.
Apr 1
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
Clorox secured new short-term financing flexibility for operational needs, indicating management confidence in near-term cash flow while adding leverage that could constrain future financial flexibility if unutilized.
Mar 10
8-K · 7.01
! Medium
Clorox Company -- 8-K 7.01: Regulation FD Disclosure
Clorox disclosed material information to investors via Regulation FD, signaling potential guidance updates or strategic announcements that could impact stock valuation and should be monitored for earnings implications.
Feb 3
Data updated apr 25, 2026 1:51am
· Source: massive.com